Clinical trials
4 active studies led by FUSMobile Inc., of 9 in all
Source: ClinicalTrials.gov, Studies with FUSMobile Inc. (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
- 0Reports naming them
- 1Markets in public records
- 0Regions & countries
- 4Active trials they lead[1]
[1] ClinicalTrials.gov, Studies led by FUSMobile Inc. or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
Free public data on FUSMobile Inc.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
See them on ClinicalTrials.gov (opens in a new tab)
Trials over time
Studies FUSMobile Inc. leads, by the year they started and their phase
- Phase 1
- Phase 2
- Phase 3
- Phase 4
- No phase (devices, observational)
Source: ClinicalTrials.gov, Studies with FUSMobile Inc. or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets where public records show them
Markets we cover where free public records show FUSMobile Inc.: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
Topics
The topics of the markets FUSMobile Inc. is in.
From our blog
Stories on the topics FUSMobile Inc. works in.
Brain Cancer Diagnosis: Imaging and New Biomarkers
About 321,000 people were diagnosed with brain and nervous system tumours in 2022, and about 248,000 died…
Read
Alzheimer's Diagnosis: Blood Tests and Earlier Answers
57 million people live with dementia. In May 2025 the US FDA cleared the first blood test used to help…
Read
Cannabis-Based Medicines: Science and Regulation
The FDA has approved one cannabis-derived medicine, Epidiolex, for rare epilepsies, and three synthetic…
Read